Envoy Medical (COCH) Financial Statements & Analysis

Envoy Medical (COCH) Income Statement

Envoy Medical reported revenue of $241.00K in fiscal 2025 (fiscal year ended Dec 31, 2025), up 7.1% from $225.00K a year earlier. Envoy Medical posted a net loss of $23.76M, compared with a net loss of $20.80M a year earlier. Gross margin was -262.7% and operating margin -9240.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $51.00K, down 34.6% from the same quarter a year earlier.

Envoy Medical Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Envoy Medical, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Mar 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.24	0.23	0.23	0.32	0.32	0.24	0.31
Cost of Revenue	0.87	0.74	0.74	0.79	0.79	0.50	0.77
Gross Profit	-0.63	-0.52	-0.52	-0.47	-0.47	-0.26	-0.46
Operating Expenses
Research & Development	12.49	10.18	10.18	8.96	8.96	4.98	3.94
Selling, General & Administrative	9.15	8.56	8.56	8.93	8.93	3.47	2.47
Operating Expenses	21.64	18.74	18.74	17.89	17.89	8.45	6.41
Operating Income	-22.27	-19.26	-19.26	-18.36	-18.36	-8.71	-6.87
Other Income/Expense
Interest Income	0.00	0.00	-	0.00	-	0.00	0.04
Interest Expense	1.59	0.82	0.82	0.00	-	0.00	0.00
Other Income/Expense	0.10	-1.54	-0.72	-11.56	-11.56	-7.22	-1.80
Income
Income Before Tax	-23.76	-20.80	-20.80	-29.92	-29.92	-15.92	-8.68
Income Tax Expense	0.00	0.00	-	0.00	-	0.00	0.00
Net Income	-23.76	-20.80	-20.80	-29.92	-29.92	-15.92	-8.68
Net Income - Continuous Operations	-23.76	-20.80	-20.80	-29.92	-29.92	-15.92	-8.68
Net Income - Discontinued Operations	-	-	-	-	-	-	-
EBITDA	-21.86	-19.81	-19.81	-29.79	-29.79	-8.63	-8.60
EBIT	-22.17	-	-19.98	-	-29.92	-8.71	-6.87
Depreciation & Amortization	0.30	0.17	0.17	0.13	0.13	0.08	0.07
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-3.00	-3.00	-2.00	-1.00
Diluted EPS	-1.00	-1.00	-1.00	-3.00	-3.00	-2.00	-1.00
Basic Shares Outstanding	23.26	18.79	18.79	12.55	12.30	10.12	10.15
Diluted Shares Outstanding	23.26	18.79	18.79	12.55	12.30	10.12	10.15

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Envoy Medical Financial Statements

What was Envoy Medical's revenue in fiscal 2025?

Envoy Medical reported revenue of $241.00K in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 7.1% from $225.00K a year earlier.

Is Envoy Medical profitable?

No. Envoy Medical reported a net loss of $23.76M in fiscal 2025. In fiscal 2024 it lost $20.80M.

What is Envoy Medical's operating margin?

Envoy Medical's operating income was −$22.27M on revenue of $241.00K in fiscal 2025, an operating margin of -9240.7%, compared with -8558.2% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition